masld glp 1 Beyond glucagon-like peptide-1: The promise of polyagonists in metabolic dysfunction–associated steatotic liver disease and metabolic dysfunction–associated steatohepatitis—A systematic review of randomized trials GLP‑1 Liver Disease: New MASLD
Description
Some are frustrated
The FDA requires this warning for all medications that contain an antidepressant
Not every person with MASH has the same fibrosis risk
Things that you talked about before and this is why when you go to a fertility clinic, they might tell you, you have to get your BMI down, which I'm like, that's not the best way to talk about someone's body composition
Compounded GLP-1s are not FDA-approved or evaluated for safety or efficacy, and not available in all states
That's a big problem for employers, who don't want to pay for the expensive drugs indefinitely
